Inhibitory effect of all-trans retinoic acid on human hepatocellular carcinoma cell proliferation

World Journal of Gastroenterology

Volumn 9, Issue 9, 2003, Pages 2117-2120

  Piao, Yun Feng ^a   Shi, Yang ^a   Gao, Pu Jun ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; RETINOIC ACID; TELOMERASE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CHROMATIN; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MICROSCOPY; MICROVILLUS; MORPHOLOGY; PROTEIN EXPRESSION; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; WESTERN BLOTTING;

EID: 0141718360     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i9.2117     Document Type: Article

References (42)

1. Mologni L, Marchesi E, Nielsen PE, Gambacorti-Passerini C. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-α and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid. Cancer Res 2001; 61: 5468-5473
2. Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minuc S, Mancini M, Pelicci PG, Lo Coco F, Nervi C. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. Cancer Res 2001; 61: 2-7
3. Manfredini R, Trevisan F, Grande A, Tagliafico E, Montanari Lemori R, Visani G, Tura S, Ferrario S. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells. Cancer Res 1999; 59: 3803-3811
4. Chung J, Liu C, Smith DE, Seitz HK, Russell RM, Wang XD. Restoration of retinoic acid concentration suppresses ethanol-enhanced c-Jun expression and hepatocyte proliferation in rat liver. Carcinogenesis 2001; 22: 1213-1219
5. Rexer BN, Zheng WL, Ong DE. Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. Cancer Res 2001; 61: 7065-7070
6. Sapi E, Flick MB, Tartaro K, Kim S, Rakhlin Y, Rodov S, Kacinski BM. Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1- induced invasion and anchorage-independent growth of human breast carcinoma cells. Cancer Res 1999; 59: 5578-5585
7. Zhu WY, Jones CS, Amin S, Matsukuma K, Haque M, Vuligonda V, Chandraratna RA, De Luca LM. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells. Cancer Res 1999; 59: 85-90
8. Miller WH Jr. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 1998; 83: 1471-1482
9. Kalemkerian GP, Jiroutek M, Ettinger DS, Dorighi JA, Johnson DH, Mabry M. A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: An Eastern Cooperative Oncology Group Study. Cancer 1998; 83: 1102-1108
10. Hatoum A, El-Sabban ME, Khoury J, Yuspa SH, Darwiche N. Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis. Carcinogenesis 2001; 22: 1955-1963
11. Schneider SM, Offterdinger M, Huber H, Grunt TW. Activation of retinoic acid receptor is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Res 2000; 60: 5479-5487
12. Ai ZW, Cha XL, Ye JN, Chen HL. Reverse effect of retinoic acid on some cell membrane phenotype of human hepatocellular carcinoma cells. Shengwu Huaxue yu Shengwu Wuli Xuebao 1990; 22: 14-150
13. Ai ZW, Cha XL, Liu Y, Chen HL. Reverse effect of retinoic acid on some cell plasma phenotype of human hepatocellular carcinoma cells. Shengwu Huaxue yu Shengwu Wuli Xuebao 1990; 22: 135-139
14. Hao MW, Liang YR, Liu YF, Wu MY, Yang HX. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World J Gastroenterol 2002; 8: 203-207
15. Ogami M, Ikura Y, Nishiguchi S, Kuroki T, Ueda M, Sakurai M. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma. Lab Invest 1999; 79: 15-26
16. Kojima H, Yokosuka O, Imazeki F, Saisho H, Omata M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 1997; 112: 493-500
17. Zhang G, Long M, Wu ZZ, Yu WQ. Mechanical properties of hepatocellular carcinoma cells. World J Gastroenterol 2002; 8: 243-246
18. Wang X, Liu FK, Li JS, Xu GX. Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro. World J Gastroenterol 2002; 8: 253-257
19. Ohno J, Horio Y, Sekido Y, Hasegawa Y, Takahashi M, Nishlzawa J, Saito H, Ishikawa F, Shimokata K. Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development. Carcinogenesis 2001; 22: 751-756
20. Blackburn EH. Structure and function of telomeres. Nature 1991; 350; 569-573
21. Figueroa R, Lindenmaier H, Hergenhahn M, Nielsen KV, Boukamp P. Telomere erosion varies during in vitro aging of normal human fibroblasts from young and adult donors. Cancer Res 2000; 60: 2770-2774
22. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-529
23. Dahse R, Fiedler W, Ernst G. Telomeres and telomerase: Biological and clinical importance. Clin Chem 1997; 43: 708-714
24. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider C, Villeponteau B. The RNA component of human telomerase. Science 1995; 269: 1236-1241
25. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015
26. Toomey D, Smyth G, Condron C, Kay E, Conroy R, Foley D, Hong C, Hogan B, Toner S, McCornick P, Broe P, Kelly C, Bouchier-Hayes D. Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: Tumor size and lymph node status remain the most important prognostic features. Cancer 2001; 92: 2648-2657
27. Hytiroglou P, Kotoula V, Thung SN, Tsokos M, Fiel MI, Papadimitriou CS. Telomerase activity in precancerous hepatic nodules. Cancer 1998; 82: 1831-1838
28. Kitamoto M, Ide T. Telomerase activity in precancerous hepatic nodules. Cancer 1999; 85: 245-248
29. Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T, Kajiyama G. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 1997; 74: 141-147
30. Yan P, Coindre JM, Benhattar J, Bosman FT, Guillou L. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors; Correlation with grade, histology, and proliferative activity. Cancer Res 1999; 59: 3166-3170
31. Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MAS. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Cancer Res 2000; 60: 610-617
32. Yan P, Saraga EP, Bouzourene H, Bosman FT, Benhattar J. Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis. J Pathol 2001; 193: 21-26
33. Youssef N, Paradis V, Ferlicot S, Bedossa P. In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis. J Pathol 2001; 194: 459-465
34. Sato N, Maehara N, Mizomoto K, Nagai E, Yasoshima T, Hirata K, Tanaka M. Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion. Cancer 2001; 91: 496-504
35. Matthews P, Jones CJ, Skinner J, Haughton M, De Micco C, Wynford-Thomas D. Telomerase activity and telomere length in thyroid neoplasia: Biological and clinical implications. J Pathol 2001; 194: 183-193
36. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, RaJu SM, Smulson ME, Yamin TT, Yu VL, Miller DK. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43
37. Wolf BB, Green DR. Suicidal tendencies: Apoptotic cell death by caspase family proteinases. J Bio Chem 1999; 274: 20049-20052
38. Marshman E, Ottewell PD, Potten CS, Watson AJ. Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol 2001; 195: 285-292
39. 1 arrest followed by necrotic cell death. Cancer Res 1999; 59: 3565-3569
40. Mori M, Terui Y, Tanaka M, Tomizuka H, Mishima Y, Ikeda M, Kasahara T, Uwai M, Ueda M, Inoue R, Itoh T, Yamada M, Hayasawa H, Furukawa Y, Ishizaka Y, Ozawa K, Hatake K. Antitumor effect of β2-microglobulin in leukemic cell-bearing mice via apoptosis-inducing activity: Activation of caspase-3 and nuclear factor-kappaB. Cancer Res 2001; 61: 4414-4417
41. Jiang C, Wang Z, Ganther H, Lu J. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res 2001; 61: 3062-3070
42. Shariat SF, Desai S, Song W, Khan T, Zhao J, Nguyen C, Foster BA, Greenberg N, Spencer DM, Slawin KM. Adenovirus-mediated transfer of inducible caspases: A novel "death switch" gene therapeutic approach to prostate cancer. Cancer Res 2001; 61: 2562-2571